Sanofi and GSK ready to seek authorization for COVID-19 vaccine

Sanofi and GSK ready to seek authorization for COVID-19 vaccine

Source: 
Biopharma Reporter
snippet: 

Releasing data from both Phase 3 and booster trials, Sanofi and GSK have announced they will submit the results as the basis for regulatory applications for their COVID-19 vaccine.